Plasmodium falciparum Falcipain-2a Polymorphisms in Southeast Asia and Their Association With Artemisinin Resistance
暂无分享,去创建一个
P. Rosenthal | G. Dong | L. Cui | Yaming Cao | J. Miao | Thanat Chookajorn | Zhao-qing Yang | Faiza Amber Siddiqui | Meilian Wang | Awtum M Brashear | Karen Kemirembe | Zenglei Wang | Mynthia Cabrera | L. Cui
[1] S. Schaffner,et al. Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia , 2017, Malaria Journal.
[2] Mehul Dhorda,et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study , 2017, The Lancet. Infectious diseases.
[3] D. Fidock,et al. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study , 2017, The Lancet. Infectious diseases.
[4] D. Kwiatkowski,et al. Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study. , 2017, The Lancet. Infectious diseases.
[5] L. Cui,et al. Limited genetic diversity in the PvK12 Kelch protein in Plasmodium vivax isolates from Southeast Asia , 2016, Malaria Journal.
[6] X. Su,et al. Genome-wide association analysis identifies genetic loci associated with resistance to multiple antimalarials in Plasmodium falciparum from China-Myanmar border , 2016, Scientific Reports.
[7] L. Tilley,et al. Haemoglobin degradation underpins the sensitivity of early ring stage Plasmodium falciparum to artemisinins , 2016, Journal of Cell Science.
[8] Saorin Kim,et al. Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations , 2015, BMC Medicine.
[9] L. Cui,et al. In Vitro Activities of Primaquine-Schizonticide Combinations on Asexual Blood Stages and Gametocytes of Plasmodium falciparum , 2015, Antimicrobial Agents and Chemotherapy.
[10] S. Meshnick,et al. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. , 2015, The Lancet. Infectious diseases.
[11] L. Cui,et al. Prevalence of K13-propeller polymorphisms in Plasmodium falciparum from China-Myanmar border in 2007–2012 , 2015, Malaria Journal.
[12] D. Kyle,et al. Artemisinin-Resistant Plasmodium falciparum Parasites Exhibit Altered Patterns of Development in Infected Erythrocytes , 2015, Antimicrobial Agents and Chemotherapy.
[13] Gilean McVean,et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum , 2015, Nature Genetics.
[14] Yang Zhang,et al. The I-TASSER Suite: protein structure and function prediction , 2014, Nature Methods.
[15] P. Rosenthal,et al. Polymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan Children , 2014, PloS one.
[16] P. Rosenthal,et al. Cross-Talk between Malarial Cysteine Proteases and Falstatin: The BC Loop as a Hot-Spot Target , 2014, PloS one.
[17] Kellen L. Olszewski,et al. Metabolic QTL Analysis Links Chloroquine Resistance in Plasmodium falciparum to Impaired Hemoglobin Catabolism , 2014, PLoS genetics.
[18] B. Genton,et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria , 2013, Nature.
[19] Koichiro Tamura,et al. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. , 2013, Molecular biology and evolution.
[20] Saorin Kim,et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. , 2013, The Lancet. Infectious diseases.
[21] L. Cui,et al. In Vitro Sensitivity of Plasmodium falciparum from China-Myanmar Border Area to Major ACT Drugs and Polymorphisms in Potential Target Genes , 2012, PloS one.
[22] Leann Tilley,et al. Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion , 2011, Proceedings of the National Academy of Sciences.
[23] K. Silamut,et al. Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.
[24] A. Sali,et al. Regulatory Elements within the Prodomain of Falcipain-2, a Cysteine Protease of the Malaria Parasite Plasmodium falciparum , 2009, PloS one.
[25] P. Rosenthal,et al. Falcipain Cysteine Proteases Require Bipartite Motifs for Trafficking to the Plasmodium falciparum Food Vacuole* , 2007, Journal of Biological Chemistry.
[26] M. Bogyo,et al. Falstatin, a Cysteine Protease Inhibitor of Plasmodium falciparum, Facilitates Erythrocyte Invasion , 2006, PLoS pathogens.
[27] P. Rosenthal,et al. Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum. , 2006, Molecular and biochemical parasitology.
[28] Xu Shen,et al. Structural and Functional Characterization of Falcipain-2, a Hemoglobinase from the Malarial Parasite Plasmodium falciparum* , 2006, Journal of Biological Chemistry.
[29] R. Fletterick,et al. Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[30] Jun Liu,et al. Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[31] P. Rosenthal,et al. The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] Vincent Danjean,et al. On the use of haplotype phylogeny to detect disease susceptibility loci , 2005, BMC Genetics.
[33] P. Rosenthal,et al. Biosynthesis, localization, and processing of falcipain cysteine proteases of Plasmodium falciparum. , 2005, Molecular and biochemical parasitology.
[34] L. Goh,et al. Homology modeling and mutagenesis analyses of Plasmodium falciparum falcipain 2A: implications for rational drug design. , 2004, Biochemical and biophysical research communications.
[35] P. Rosenthal,et al. Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[36] P. Rosenthal,et al. Independent Intramolecular Mediators of Folding, Activity, and Inhibition for the Plasmodium falciparum Cysteine Protease Falcipain-2* , 2004, Journal of Biological Chemistry.
[37] P. Rosenthal,et al. Folding of the Plasmodium falciparum Cysteine Protease Falcipain-2 Is Mediated by a Chaperone-like Peptide and Not the Prodomain* , 2002, The Journal of Biological Chemistry.
[38] Ashutosh Kumar Singh,et al. Characterization of Native and Recombinant Falcipain-2, a Principal Trophozoite Cysteine Protease and Essential Hemoglobinase ofPlasmodium falciparum * , 2000, The Journal of Biological Chemistry.
[39] P. Rosenthal,et al. Plasmodium falciparum: inhibitors of lysosomal cysteine proteinases inhibit a trophozoite proteinase and block parasite development. , 1989, Molecular and biochemical parasitology.
[40] P. Rosenthal,et al. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. , 1988, The Journal of clinical investigation.
[41] W. Trager,et al. Human malaria parasites in continuous culture. , 1976, Science.
[42] R. Fairhurst,et al. Artemisinin-Resistant Plasmodium falciparum Malaria. , 2016, Microbiology spectrum.